Cp. Ceberg et al., ENHANCED BORON UPTAKE IN RG-2 RAT GLIOMAS BY ELECTROPERMEABILIZATION IN-VIVO - A NEW POSSIBILITY IN BORON NEUTRON-CAPTURE THERAPY, Anti-cancer drugs, 5(4), 1994, pp. 463-466
Accumulation of boron in tumor tissue is an indispensable requirement
for boron neutron capture therapy and it is important that the uptake
is as high as possible. In this work we have studied the influence of
electropermeabilization in vivo on the uptake of boron in normal and R
G 2 glioma bearing Fischer 344 rats. Two different boron compounds, a
sulfhydryl boron hydride (BSH) and a boronated porphyrin (BOPP), have
been investigated. The rats were infused intravenously during 5 min wi
th 175 mug BSH/g body weight or 12 mug BOPP/g body weight. Two electro
des were placed 5 mm apart in the brain and electropermeabilization wa
s performed with eight square 400 V pulses at 4 and 7 min after the en
d of the infusion. After 6 h the animals were killed, and the boron co
ntent in the tumors and the surrounding brain was measured with neutro
n-activated autoradiography. In electropermeabilized healthy animals t
he BOPP uptake was low and limited to the electrode lessons, whereas B
SH was spread extensively throughout the hemisphere. Rats with gliomas
showed doubled (BOPP) to 10-fold (BSH) uptake of boron in the tumor w
hen electropermeabilization was performed as compared with untreated a
nimals. We conclude that electropermeabilization in the future may pro
vide an interesting possibility to increase the uptake of certain boro
n compounds before neutron capture therapy.